Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
Clinical trial NCT05142592 · COMPLETED
Trial details
- NCT number
- NCT05142592
- Sponsor
- Nanjing Immunophage Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2026-02-08
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.